Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2011, Article ID 638020, 4 pages
http://dx.doi.org/10.1155/2011/638020
Case Report

Lenalidomide-Associated ITP

1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
2Stem Cell Therapy, Duke University Medical Center, Durham, NC 27710, USA
3Division of Hematology, Duke University Medical Center, Durham, NC 27710, USA

Received 27 April 2011; Accepted 25 May 2011

Academic Editors: M.-C. Kyrtsonis, T. Sonoki, S. Storti, J. Várkonyi, and S. D. Wagner

Copyright © 2011 Christina I. Herold et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Teo, “Properties of thalidomide and its analogues: implications for anticancer therapy,” AAPS Journal, vol. 7, no. 1, article 3, pp. E14–E19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Okafor, “Thalidomide for erythema nodosum leprosum and other applications,” Pharmacotherapy, vol. 23, no. 4, pp. 481–493, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Lazzerini, S. Martelossi, F. Marchetti et al., “Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 4, pp. 419–427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ossandon, E. A. M. Cassará, R. Priori, and G. Valesini, “Thalidomide: focus on its employment in rheumatologic diseases,” Clinical and Experimental Rheumatology, vol. 20, no. 5, pp. 709–718, 2002. View at Google Scholar · View at Scopus
  5. K. C. Conlon, W. J. Urba, J. W. Smith II, R. G. Steis, D. L. Longo, and J. W. Clark, “Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy,” Cancer, vol. 65, no. 10, pp. 2237–2242, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Erdem, M. Gundogdu, I. Kiki, and I. Çapoĝlu, “Autoimmune thyroiditis during thalidomide treatment,” American Journal of Hematology, vol. 81, no. 2, p. 152, 2006. View at Publisher · View at Google Scholar
  7. E. M. Stein and C. Rivera, “Transient thyroiditis after treatment with lenalidomide in a patient with metastatic renal cell carcinoma,” Thyroid, vol. 17, no. 7, pp. 681–683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. D. Verdirame, J. R. Feagler, and J. R. Commers, “Multiple myeloma associated with immune thrombocytopenic purpura,” Cancer, vol. 56, no. 5, pp. 1199–1200, 1985. View at Google Scholar · View at Scopus
  9. V. Gupta, U. M. Hegde, R. Parameswaran, and A. C. Newland, “Multiple myeloma and immune thrombocytopenia,” Clinical and Laboratory Haematology, vol. 22, no. 4, pp. 239–242, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. Corporation C. REVLIMID (lenalidomide) Prescribing Information. Summit, NJ, USA, 2009.
  11. R. H. Aster, “Can drugs cause autoimmune thrombocytopenic purpura?” Seminars in Hematology, vol. 37, no. 3, pp. 229–238, 2000. View at Google Scholar · View at Scopus
  12. P. Griem and E. Gleichmann, “Metal ion induced autoimmunity,” Current Opinion in Immunology, vol. 7, no. 6, pp. 831–838, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Crane and A. List, “Immunomodulatory drugs,” Cancer Investigation, vol. 23, no. 7, pp. 625–634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Fehérvari and S. Sakaguchi, “CD4+ trregs and immune control,” Journal of Clinical Investigation, vol. 114, no. 9, pp. 1209–1217, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Galustian, B. Meyer, M. C. Labarthe et al., “The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells,” Cancer Immunology, Immunotherapy, vol. 58, no. 7, pp. 1033–1045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. C. Filion, C. Proulx, A. J. Bradley et al., “Presence in peripheral blood of healthy individuals of autoreactive T cells to a membrane antigen present on bone marrow-derived cells,” Blood, vol. 88, no. 6, pp. 2144–2150, 1996. View at Google Scholar · View at Scopus